Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 95 (6) , 551-557
- https://doi.org/10.1016/s1081-1206(10)61018-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studiesAnnals of Allergy, Asthma & Immunology, 2004
- A review of montelukast in the treatment of asthma and allergic rhinitisExpert Opinion on Pharmacotherapy, 2004
- Etiopathogenesis and Management of Perennial Allergic RhinitisTreatments in Respiratory Medicine, 2004
- Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment periodAllergy, 2003
- Seasonal versus Perennial Allergic Rhinitis: Drug and Medical Resource Use PatternsValue in Health, 2003
- Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Montelukast for treating seasonal allergic rhinitis: a randomized, double‐blind, placebo‐controlled trial performed in the springClinical and Experimental Allergy, 2002
- Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fallAnnals of Allergy, Asthma & Immunology, 2002
- Allergic Rhinitis and Its Impact on AsthmaJournal of Allergy and Clinical Immunology, 2001
- Systemic immunologic and inflammatory aspects of allergic rhinitisJournal of Allergy and Clinical Immunology, 2000